Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.27, $0.09 better than the analyst estimate of $0.18. Revenue for the quarter came in at $369.2 million versus the consensus estimate of $375.39 million.

GUIDANCE:

Allscripts sees FY2021 revenue of $1.5 billion, versus the consensus of $1.5 billion.

For earnings history and earnings-related data on Allscripts (MDRX) click here.